Codiak BioSciences gets grant for extracellular vesicles for disease treatment and prevention

Discover Codiak BioSciences’ groundbreaking patent on engineered extracellular vesicles (EVs) for targeted disease treatment, including cancer and infections.

Ozanimod Controls MS Disease Activity Regardless of Age

WEST PALM BEACH, Fla. — Clinical and radiologic measures of disease activity remained stable or improved for relapsing multiple sclerosis (RMS) patients in all age

March 4, 2024

The highs — and lows — of JPM 2024 you should pay attention to

In honor of JPM Week, you’re reading a special edition of our biotech newsletter, The Readout. To stay on top of the latest scoops and

January 11, 2024

MorphoSys To Showcase Phase 3 MANIFEST-2 Data on Pelabresib in Myelofibrosis in Oral Presentation at 2023 ASH Annual Meeting – Biotech Investments

EQS-News: MorphoSys AG / Key word(s): Miscellaneous MorphoSys To Showcase Phase 3 MANIFEST-2 Data on Pelabresib in Myelofibrosis in Oral Presentation at 2023 ASH Annual

November 3, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.